Changes in behavior and gene expression induced by caloric restriction in C57BL/6 mice

Physiological Genomics

Volumn 39, Issue 3, 2009, Pages 227-235

  Yamamoto, Yuta ^a   Tanahashi, Toshihito ^a   Kawai, Tomoko ^a   Chikahisa, Sachiko ^a   Katsuura, Sakurako ^a   Nishida, Kensei ^a   Teshima Kondo, Shigetada ^a   Sei, Hiroyoshi ^a   Rokutan, Kazuhito ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anxiety; Depression; Ingenuity pathway analysis; Mouse amygdala

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CYCLIC AMP; DOPAMINE RECEPTOR; PHOSPHOPROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CALORIC RESTRICTION; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; DNA MICROARRAY; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; MALE; MAZE TEST; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REFEEDING; SIGNAL TRANSDUCTION; SWIMMING; UPREGULATION; WESTERN BLOTTING;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BODY WEIGHT; CALORIC RESTRICTION; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; EATING; GENE EXPRESSION PROFILING; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SWIMMING;

MUS;

EID: 72949087976     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00082.2009     Document Type: Article

References (45)

1. Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA, Mattson MP. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci USA 100: 6216-6220, 2003.
2. Baragli A, Grieco ML, Trieu P, Villeneuve LR, Hebert TE. Heterodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Galpha s. Cell Signal 20: 480-492, 2008.
3. National Task Force on the Prevention and Treatment of Obesity. Dieting and the development of eating disorders in overweight and obese adults. Arch Intern Med 160: 2581-2589, 2000.
4. Bourin M, Hascoet M. The mouse light/dark box test. Eur J Pharmacol 463: 55-65, 2003.
5. Bunger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, Muller M. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol Genomics 30: 192-204, 2007.
6. Challen G, Gardiner B, Caruana G, Kostoulias X, Martinez G, Crowe M, Taylor DF, Bertram J, Little M, Grimmond SM. Temporal and spatial transcriptional programs in murine kidney development. Physiol Genomics 23: 159-171, 2005.
7. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13: 167-170, 1980.
8. Duan W, Mattson MP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res 57: 195-206, 1999.
9. Franklin KBJ, Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. Academic Press San Diego, 1996.
10. Fu C, Hickey M, Morrison M, McCarter R, Han ES. Tissue specific and non-specific changes in gene expression by aging and by early stage CR. Mech Ageing Dev 127: 905-916, 2006.
11. Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 73: 941-949, 2006.
12. Goodrick CL, Ingram DK, Reynolds MA, Freeman JR, Cider NL. Effects of intermittent feeding upon growth, activity, and lifespan in rats allowed voluntary exercise. Exp Aging Res 9: 203-209, 1983.
13. Han ES, Hickey M. Microarray evaluation of dietary restriction. J Nutr 135: 1343-1346, 2005.
14. Hemmings HC Jr, Greengard P, Tung HY, Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310: 503-505, 1984.
15. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29: 1201-1213, 2005.
16. Jahng JW, Kim JG, Kim HJ, Kim BT, Kang DW, Lee JH. Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res 1150: 100-107, 2007.
17. Kuma Y, Campbell DG, Cuenda A. Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38beta. Biochem J 379: 133-139, 2004.
18. Levay EA, Govic A, Penman J, Paolini AG, Kent S. Effects of adult-onset calorie restriction on anxiety-like behavior in rats. Physiol Behav 92: 889-896, 2007.
19. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92: 180-185, 1987.
20. Marinkovic P, Pesic V, Loncarevic N, Smiljanic K, Kanazir S, Ruzdijic S. Behavioral and biochemical effects of various food-restriction regimens in the rats. Physiol Behav 92: 492-499, 2007.
21. Martin B, Mattson MP, Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev 5: 332-353, 2006.
22. Martin B, Pearson M, Brenneman R, Golden E, Keselman A, Iyun T, Carlson OD, Egan JM, Becker KG, Wood W 3rd, Prabhu V, de Cabo R, Maudsley S, Mattson MP. Conserved and differential effects of dietary energy intake on the hippocampal transcriptomes of females and males. PLoS One 3: e2398, 2008.
23. Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 16: 129-137, 2005.
24. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 117: 672-682, 2007.
25. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159, 2006.
26. Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P. Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci USA 97: 12840-12845, 2000.
27. Nunez Rodriguez N, Lee IN, Banno A, Qiao HF, Qiao RF, Yao Z, Hoang T, Kimmelman AC, Chan AM. Characterization of R-ras3/m-ras null mice reveals a potential role in trophic factor signaling. Mol Cell Biol 26: 7145-7154, 2006.
28. Pacak K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 22: 502-548, 2001.
29. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30: 375-381, 2007.
30. Paylor R, Spencer CM, Yuva-Paylor LA, Pieke-Dahl S. The use of behavioral test batteries, II: effect of test interval. Physiol Behav 87: 95-102, 2006.
31. Prica C, Hascoet M, Bourin M. Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression. Behav Brain Res 191: 49-54, 2008.
32. Prolla TA. DNA microarray analysis of the aging brain. Chem Senses 27: 299-306, 2002.
33. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33, 2003.
34. Ramos A. Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci 29: 493-498, 2008.
35. Reuter M, Weber B, Fiebach CJ, Elger C, Montag C. The biological basis of anger: associations with the gene coding for DARPP-32 (PPP1R1B) and with amygdala volume. Behav Brain Res 202: 179-183, 2009.
36. Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE. Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther 113: 134-153, 2007.
37. Stunkard AJ. The dieting depression; incidence and clinical characteristics of untoward responses to weight reduction regimens. Am J Med 23: 77-86, 1957.
38. Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci USA 99: 3188-3193, 2002.
39. Swindell WR. Comparative analysis of microarray data identifies common responses to caloric restriction among mouse tissues. Mech Ageing Dev 129: 138-153, 2008.
40. Taylor CB, Ferguson JM, Reading JC. Gradual weight loss and depression. Behavior Therapy 9: 622-625, 1978.
41. Wadden TA, Stunkard AJ. Controlled trial of very low calorie diet, behavior therapy, and their combination in the treatment of obesity. J Consult Clin Psychol 54: 482-488, 1986.
42. Walaas SI, Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 4: 84-98, 1984.
43. Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 17: 30-36, 1994.
44. Wing RR, Marcus MD, Epstein LH, Kupfer D. Mood and weight loss in a behavioral treatment program. J Consult Clin Psychol 51: 153-155, 1983.
45. Zhu H, Guo Q, Mattson MP. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res 842: 224-229, 1999.